| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| PIK3CA |
4,4'-Dimethoxybenzoin |
NA |
1170000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CA |
IC-87114 |
NA |
200000|255000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CB |
11-(3-Methoxyphenyl)-13-morpholin-4-yl-8-phenyl-6,8,10,12-tetrazatricyclo[7.4.0.02,6]trideca-1(13),9,11-triene-7-thione |
NA |
113450 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CB |
13-Morpholin-4-yl-11-(morpholin-4-ylmethyl)-8-phenyl-6,8,10,12-tetrazatricyclo[7.4.0.02,6]trideca-1(13),9,11-triene-7-thione |
NA |
323450 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CB |
13-Morpholin-4-yl-11-(1-morpholin-4-ylethyl)-8-phenyl-6,8,10,12-tetrazatricyclo[7.4.0.02,6]trideca-1(13),9,11-triene-7-thione |
NA |
418160 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CB |
4-(2-Amino-1,3-benzothiazol-6-yl)-1-(2-methoxyethoxy)pyridin-2-one |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| PIK3CB |
1-(Cyclopropylmethyl)-4-[2-(oxan-4-ylmethylamino)-1,3-benzothiazol-6-yl]pyridin-2-one |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| PIK3CB |
1-(cyclopropylmethyl)-4-[2-[[(1R)-1-(oxan-4-yl)ethyl]amino]-1,3-benzothiazol-6-yl]pyridin-2-one |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| PIK3CB |
1-(cyclopropylmethyl)-4-[2-[[(1S)-1-(oxan-4-yl)ethyl]amino]-1,3-benzothiazol-6-yl]pyridin-2-one |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| PIK3CB |
1-(Cyclopropylmethyl)-4-[2-[(1,1-dioxothian-4-yl)methylamino]-1,3-benzothiazol-6-yl]pyridin-2-one |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| PIK3CB |
trans-4-(((6-(1-(Cyclopropylmethyl)-2-oxo-1,2-dihydropyridin-4-yl)benzo[d]thiazol-2-yl)amino)methyl)cyclohexane-1-carboxylic acid |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| PIK3CB |
2-[[4-(4-Methoxy-2-methylphenyl)triazol-1-yl]methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one |
NA |
355000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CB |
5-Methyl-3-(2-methylphenyl)-2-[(4-phenyltriazol-1-yl)methyl]quinazolin-4-one |
NA |
430000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PIK3CB |
PI3K/mTOR Inhibitor-7 |
NA |
233000 |
NA |
NA |
NA |
NA |
BindingDB |
| PIK3CB |
2,4-diamino-6-[(2S,5S)-2-[3-(3-fluorophenyl)-5-(5-methoxypyridin-3-yl)-4-oxoquinazolin-2-yl]-5-methylpyrrolidin-1-yl]pyrimidine-5-carbonitrile |
NA |
429000 |
NA |
NA |
NA |
NA |
BindingDB |
| PIK3CB |
2,4-diamino-6-[(2S,5S)-2-(6,8-difluoro-4-oxo-3-pyridin-3-ylquinazolin-2-yl)-5-methylpyrrolidin-1-yl]pyrimidine-5-carbonitrile |
NA |
445000 |
NA |
NA |
NA |
NA |
BindingDB |
| PIK3CB |
4-[(2S,3aS,7aS)-2-(5-fluoro-4-oxo-3-pyridin-3-ylquinazolin-2-yl)-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-2,6-diaminopyrimidine-5-carbonitrile |
NA |
1548000 |
NA |
NA |
NA |
NA |
BindingDB |
| PIK3CB |
2,4-diamino-6-[(2S,5S)-2-[5-chloro-3-(3-fluorophenyl)-4-oxoquinazolin-2-yl]-5-methylpyrrolidin-1-yl]pyrimidine-5-carbonitrile |
NA |
412000 |
NA |
NA |
NA |
NA |
BindingDB |
| PIK3CB |
Theophylline |
NA |
800000 |
NA |
NA |
NA |
NA |
PubChem|TTD |
| PIK3CB |
Caffeine |
NA |
400000 |
NA |
NA |
NA |
NA |
PubChem|TTD |